ImmunologybioRxivPreprint
Anti-Asialo GM1 treatment during secondary Toxoplasma gondii infection is lethal and depletes T cells
Daria L. Ivanova, Steve L. Denton, Jason P. Gigley
This study shows that anti-ASGM1 treatment during secondary Toxoplasma gondii infection causes 100% mortality and depletes T cells, particularly CD8+ effector T cells, highlighting ASGM1 as a marker of activated T cells.
DOI 10.1101/550608